Leiping Q. Wang
270 Dong An Road
Shanghai, 200032, China
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Phase II Clinical Study of Adebrelimab and Bevacizumab Combined With Cisplatin/Carboplatin in Patients With Triple-Negative Breast Cancer With Brain Metastases (ABC Study).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 04, 2026
Efficacy and safety of ARX788 for individuals with HER2-positive breast cancer and brain metastases (ACE-Breast-06): a single-arm, phase 2 trial in China.
Journal: EClinicalMedicine
Published: July 31, 2025
Clinical and genomic characteristics of HER2-ultralow breast cancer and implications for T-DXd therapy.
Journal: Precision clinical medicine
Published: July 19, 2025
Development and validation of nomograms of outcomes for first-line platinum-based chemotherapy for metastatic triple-negative breast cancer: patient-level analysis of five prospective clinical trials in China.
Journal: Therapeutic advances in medical oncology
Published: July 14, 2025
Dalpiciclib combined with pyrotinib and endocrine therapy in women with ER-positive, HER2-positive advanced breast cancer: A prospective, multicenter, single-arm, phase 2 trial.
Journal: PLoS medicine
Published: October 25, 2024
ACE-Breast-02: a randomized phase III trial of ARX788 versus lapatinib plus capecitabine for HER2-positive advanced breast cancer.
Journal: Signal transduction and targeted therapy
Published: September 01, 2024
Clinicopathological characteristics, evolution, and treatment outcomes of hormone receptor-negative/HER2-low metastatic breast cancer: a pooled analysis of individual patient data from three prospective clinical trials.
Journal: Frontiers in endocrinology
Published: June 14, 2024
The trend of birth weight of full-term newborns and its association with parental reproductive age in Chongqing municipality from 2010 to 2022
Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
Published: November 26, 2023
Analysis of clinical features, genomic landscapes and survival outcomes in HER2-low breast cancer.
Journal: Journal of translational medicine
Published: October 20, 2022
Landscape of DNA damage response gene alterations in breast cancer: A comprehensive investigation.
Journal: Cancer
Published: August 15, 2022
Comparison of two regimens of weekly paclitaxel plus gemcitabine in patients with metastatic breast cancer: propensity score-matched analysis of real-world data.
Journal: Therapeutic advances in drug safety
Published: July 28, 2022
Last Updated: 09/26/2026